ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Net margin 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) net profit margin by fiscal year — reported net income divided by reported revenue.
-21.5%FY2025 · since FY2017: -111.4% → -21.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -21.5% | +67.6 pp |
| FY2024 | -89.1% | +43.2 pp |
| FY2023 | -132.3% | -24.3 pp |
| FY2022 | -108.0% | +26.3 pp |
| FY2021 | -134.3% | +14.3 pp |
| FY2020 | -148.6% | -68.0 pp |
| FY2019 | -80.6% | +2.8 pp |
| FY2018 | -83.4% | +28.0 pp |
| FY2017 | -111.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADPT financial trends
ADPT RevenueADPT Net incomeADPT Gross profitADPT Gross marginADPT Operating incomeADPT Operating marginADPT Operating cash flowADPT Free cash flowADPT Capital expendituresADPT Return on equityADPT Stock buybacksADPT Dividends paidADPT Total assetsADPT Total liabilitiesADPT Shareholders’ equityADPT overview →